Axel Johnson investment fund Novax co-led a $15.3m round for the vegan protein and dairy substitute developer with Capricorn Partners Sustainable Chemistry Fund.

The Lloyds Banking subsidiary has backed e-commerce fulfilment platform developer James and James, providing $15.5m in funding.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

George Health Enterprises and its subsidiary George Medicines have raised a combined $35m in funding from investors including Bupa Australia to drive pipeline development and commercialisation.

Juniper Networks, Intel and IBM returned for a round led by Dell Technologies Capital that took the application development platform's total funding to $77m.

Horizon Blue Cross Blue Shield of New Jersey took part in an equity and debt round for medical communication app developer led by Health Catalyst Capital.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Japan Post Capital contributed to a $26.4m round for the direct-to-consumer marketing and human resources technology provider, bringing its total funding to more than $62m.

Cinclus Pharma has lured back corporate venturing unit Recipharm Venture Fund for a $26.4m round that will fund a phase 2 study for its GERD therapy candidate.

The round increased the total raised by the Alibaba, Sony, WndrCo, 21st Century Fox, Walt Disney, WarnerBros and Entertainment One-backed short-form streaming startup to $1.75bn.